Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas
Condition: Type 1 Diabetes Mellitus Interventions: Drug: Humalog; Drug: Novolog; Drug: Apidra; Device: Bionic Pancreas Sponsors: Massachusetts General Hospital; Boston University Not yet recruiting - verified August 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials